2023
DOI: 10.1111/hepr.13943
|View full text |Cite
|
Sign up to set email alerts
|

Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease

Hiroaki Takaya,
Shunichi Ueyama,
Yui Osaki
et al.

Abstract: AimPatients with nonalcoholic fatty liver disease (NAFLD) are reported to have greater coronavirus disease 2019 (COVID‐19) severity compared with patients without NAFLD. Previous studies have reported that noninvasive liver fibrosis scores, including the Fibrosis‐4 index, NAFLD fibrosis score, and aspartate aminotransferase to platelet ratio index (APRI), have utility in predicting COVID‐19 mortality and disease severity in patients without NAFLD. However, the utility of liver fibrosis scores in predicting COV… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…Especially in viral infections such as covid 19, the APRI score, which can show the severity of the infection, continues to be interesting (24,25). In our study, it will be instrumental in putting forward the idea that the APRI score can be put into practical use in the field of obstetrics.…”
Section: Resultsmentioning
confidence: 90%
“…Especially in viral infections such as covid 19, the APRI score, which can show the severity of the infection, continues to be interesting (24,25). In our study, it will be instrumental in putting forward the idea that the APRI score can be put into practical use in the field of obstetrics.…”
Section: Resultsmentioning
confidence: 90%